MSFrontier

TERI-DYNAMIC

Exploratory Open Label Study to Investigate the Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Relapsing Forms of Multiple Sclerosis
CompletedPhase 3Relapsing MS2012-005324-16

What was tested

Treatment tested

What it measured

Main measures

  • Change from baseline in Lymphocyte subset parameters as

    Immune response

Other measures (1)

  • 1) Change from baseline in biased T cell clonal repertoire based T

Loading reviews and guidelines…

Related trials

  • TWINS

    Phase 3 · Not yet recruiting

    Still running

  • ENSURE-2

    Phase 3 · Moved to EU CTIS registry

  • AIOLOS

    Recruiting

    Still running

  • ENSURE-1

    Phase 3 · Completed

  • FENhance 2

    Phase 3 · Running, not recruiting

    Still running

  • FENhance

    Phase 3 · Running, not recruiting

    Still running

History

  1. In scope changed from true to false

  1. Started

    Apr 2013

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error